Skip to main content
. 2015 Feb 13;83(3):863–875. doi: 10.1128/IAI.02707-14

TABLE 1.

Pseudomonas aeruginosa strains used in this study

Strain Description Reference(s)
PAO1 Wild-type strain used for mutational analysis in this and previous studies; originally isolated from a human wound in 1955 in Australia 75
ΔprrF1,2 mutant Deletion mutant of entire prrF locus in PAO1 32
PAO1/pVLT31 Wild-type PAO1 strain carrying the pVLT31 broad-host-range vector (Tcr) 33
ΔprrF1,2/pVLT31 mutant ΔprrF1,2 mutant carrying the pVLT31 broad-host-range vector (Tcr) 33
ΔprrF1,2/pVLT-prrF1,2 mutant ΔprrF1,2 mutant carrying the prrF1,2 complementation construct (Tcr) 32
PA14 Clinical isolate from 1995 at the Massachusetts General Hospital, Boston, MA; virulent in a variety of plant and animal models of infection 56
FRD1 Mucoid clinical isolate in a sputum sample from a cystic fibrosis patient 57
WR5 Clinical isolate from a burn patient at Walter Reed Army Hospital, Washington, DC, in 1976; natural toxA mutant isolate; virulent in exptl mouse models 54, 55